Fingerprint
Dive into the research topics of 'Randomized open label phase III trial of irinotecan plus capecitabine versus capecitabine monotherapy in patients with metastatic breast cancer previously treated with anthracycline and taxane: Proceed trial (KCSG BR 11-01)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically